Comments to Authors:
In this single centre, observational cohort study, the authors report on the characteristics and outcomes of patients with prolonged noninvasive ventilation, as well as the resource use associated with this. I have several comments regarding the study and the manuscript. Comments. 1. Methods: Please provide some more characteristics of the ICU where this study was performed, such as number of beds and number of admissions per year. 2. Methods: "We defined the subjects who used NIV more than 14 days as prolonged NIV." Why 14 days and not for example 7? Please provide a justification for this cut-off and, if possible, a reference. For example, the WIND study (Beduneau G, Pham T, Schortgen F, et al: Epidemiology of Weaning Outcome according to a New Definition. The WIND Study. Am J Respir Crit Care Med 2017, 195(6):772-783.) provided some insights into the effects of prolonged weaning in patients on invasive mechanical ventilation, with increased mortality in patients still requiring ventilation on day 7 and after following the first separation attempt. 3 . Explain what is meant by S/T setting of NIV. Is this bilevel positive airway pressure (BPAP), in an assist control or pressure support mode? 4. The authors state that patients who reached intubation criteria (so basically failed NIV) but had a not-to-intubate order, were continued on NIV. These patients form a significant proportion of patients who received NIV > 14 days in this study (27.5%). Was continuation of NIV in this specific subgroup of patients perhaps part of a palliative care plan? In any instance, this is a complex issue, with significant between countries and between cultures differences. The observed results of this study are therefore difficult to extrapolate outside of the setting where this study was performed. For example, in many settings, when NIV fails and a patient is not for intubation, NIV would be ceased and the goals of care would be changed to comfort care. The association of do-notintubate order with prolonged NIV as reported by the authors fully depends on the end-of-life decisions made in situations like these. In a health care system where end-of-life and withdrawal of NIV is common practice in patients who fail NIV and are not for intubation, the NIV duration likely would be shorter, not longer. The authors could expand on this issue in the discussion. The process and reasons for do-not-intubate orders in the hospital this study was performed would also be of value to readers. What was the role of the patient in the decision-making process? 5. Please provide (as supplemental files) the process and results of the univariate and multiple logistic regression analysis to identify predictors for prolonged NIV. 6. Please describe the methods (including statistics) used to identify independent risk factors for death in hospital, as reported in Table 4 . 7. It is not surprising that patients who require prolonged NIV occupy more NIV days; these variables are mathematically coupled. NIV days may not be the best metric for resource use. An alternative would be ICU and/or hospital length of stay. If this is used, it is important to define how patients who have died in ICU/hospital were handled. Other examples of commonly reported outcome measures are: ventilator-free days to day 28 (or any other pre-specified day), vasopressor-free days to day 28, renal replacement-free days to day 28; patients who die prior to day 28 are assigned zero organ support-free days. 8. "Low oxygenation" (P/F ratio < 150) was associated with prolonged NIV; prolonged NIV was associated with increased mortality. This is consistent with recently reported outcomes of NIV in ARDS patients (Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome. Insights from the LUNG SAFE Study. Am J Respir Crit Care Med 2017; 195: 67-77). According to this study, NIV was used in 15% of patients with ARDS, irrespective of severity category. NIV appeared to be associated with higher ICU mortality in patients with a PaO2/FiO2 lower than 150 mmHg. 9. The authors could expand on the study limitations. At a minimum, they should emphasise this is a single centre observational study. Also, the baseline characteristics between the 2 groups were significantly different, with more patients having pneumonia and lung cancer in the long NIV group. Thank you for the opportunity to review this manuscript.
REVIEWER
Dellamonica, Jean CHU de Nice France REVIEW RETURNED 14-Nov-2017
GENERAL COMMENTS
Review :
Dear editor, thank you for giving me the opportunity to review the manuscript by Duan and collaborators on prolonged NIV.
I have major concerns
The subject developed by authors is interesting but very difficult to manage because of inclusions criteria. Most patients have prolonged NIV because of DNR and Do Not Intubate Order. VNI indication is then not a medical argued therapeutic choice. Thus, the signification of the results shown here should be very cautiously examined. Table 3 : severe hypoxemia (PaO2/FiO2<150) at the first day is independently associated to prolonged NIV. Specifical analysis of these patients should be performed to understand their prognostic and associated factors.
Among the results the comparison of the NIV days "used" by patients ventilated 7 days or more should be analyzed with the perspective of mortality, morbidity and costs.
The statistical analysis should be totally revised, DNI order and prolonged NIV shouldn't be analyzed separately because they are confounding factors.
Finally, Analyze of resource used (NIV days "used" by patients ventilated 7 days or more) is a good idea but it should be analyzed with the perspective of mortality, morbidity and costs.
Conclusion: To my point, the question of this manuscript should be readdressed and the analysis of prolonged VNI should be done on the light of DNI order. The main subject here is the ventilation for DNR patients. Furthermore, the time of DNR decision is crucial for the discussion, was it defined before or at ICU admission or latter after a first line treatment failure ?
This manuscript needs English editing. Page 8 line 49: change avoid aspiration for "to limit aspiration risk" Page 9 line 10: I don't understand the sentence: "Intubation was referenced the criteria we described previously.
REVIEWER
George L. Anesi, MD University of Pennsylvania, Philadelphia, PA, USA REVIEW RETURNED 08-Jan-2018
GENERAL COMMENTS
This manuscript is a single-center observational study of patients being treated exclusively with non-invasive ventilation (NIV) during admission to the ICU with the goal of identifying predictors of prolonged NIV and hospital mortality. Findings included identification of DNR status, pH, HR, and P/F ratio as predictors of prolonged NIV, and an association between prolonged NIV and increased mortality. This study has a number of strengths including primarily the needed goal of expanding our understanding of NIV usage and associated outcomes, and the expanded use of NIV for prolonged periods of time.
The study has some important limitations detailed below. Most importantly, the rationale and impact of the study population restriction to those who received only NIV throughout their ICU stay needs to be further justified and discussed. Major Comments: 1. The stated study format needs to be clarified some. The question of whether prolonged NIV predicts hospital mortality is a cohort study. 
This is interesting work with a useful dataset. However, the description of the statistical analysis needs some minor (and easy) revisions. First, it is not clear how many models were fit and which variables were used for each one. There are variables that were collected at the beginning of NIV, again on the first day of NIV and again on day 7. I'm not sure what the difference is between the beginning of NIV and the first day of NIV. They sound like the same thing but I'm guessing that the first set of measurements were take prior to NIV while the second set were taken afterwards. How long did you wait for the second ones? I'm also not sure how many models were fit. Was there one model for the beginning, one for the first day, and one for day 7? Did the one for day 1 also use measurements from the beginning or only the measurements for day 1? Was there one model for each of the four outcomes in Table 1 ? Given that less than a quarter of patients received NIV for 7 days, the information at day 7 seems to be aimed at a different question: "who will experience prolonged NIV given that they receive at least 7 days" as opposed to "who will experience NIV?" In summary, the manuscript should clearly state how many models were fit, and which variables were used as candidates to fit each model.
A second problem is that if you are proposing that these variables might be useful for predicting prolonged NIV, then it is important to provide some measure of predictive power. The usual way to do that is by reporting a c-statistic or, equivalently, area under the ROC curve, for each model so that readers can get some sense of how well these variables predict the outcomes.
As a final point, let me also suggest that you may be missing an opportunity by not examining associations between change in the various physiological measures from before to after receiving NIV. For example, the mean heart rate dropped substantially after receiving NIV. It seems likely that some patients experienced larger drops than others and that the magnitude of the drop might well be at least as predictive as the fvalue itself. This is certainly not necessary to rewriting the current manuscript so I leave it up to you as to whether or not you would like to pursue it.
REVIEWER

Jessica Kasza
Monash University, Australia REVIEW RETURNED 13-Feb-2018
GENERAL COMMENTS
Using data collected from the intensive care unit of a single hospital over the period from 2011-2017, the aim of this study is to characterise patients undergoing non-invasive ventilation (NIV), and investigate the resource use and outcomes of these patients. The authors defined prolonged NIV as NIV that was administered for 14 or more days. My comments on the statistical aspects of this study are below.
1. Much of the analysis focusses on splitting patients into those with and without prolonged NIV, where the definition of prolonged NIV is NIV lasting for 14 or more days. This dichotomisation appears to be somewhat arbitrary: why not define prolonged NIV as that which lasts for 10 or more days, for example. Although it is useful to categorise NIV duration when comparing resource use, it may be more informative to analyse duration of NIV using Cox proportional hazards models, for example. This would then allow consideration of the impact of characteristics on the hazard of NIV discontinuation.
2. How were deaths dealt with in the analysis? It is possible that patients who died after starting NIV, but prior to 14 days on NIV were sicker in measured and unmeasured ways than patients who remained on NIV. Were patients who died prior to 14 days on NIV included in the analysis? What impact might this have on estimated associations?
3. It is unclear to me how the results reported in Tables 3 and 4 align with the analysis described on lines 37-52 of page 8 of the manuscript. I have a number of comments about these tables: a. On page 8, it is stated that "…variables with p-value less than 0.2 in univariate analysis were analysed by stepwise multiple logistic regression analysis to find the independent risk factor for prolonged NIV." Was the same method applied to obtain the results in Table 4 ? b. What was the complete set of variables considered for each of these outcomes? The results of fitting the univariable models should also be presented in these tables, as well as the results of the multivariable models. c. Was forward or backward stepwise regression used? Stepwise approaches to building regression models are generally not recommended, due to p-values not accurately reflecting the entire model-building process. P-values from models built in this way should be interpreted very cautiously. d. Table 3 : were "Variables collected at the beginning of NIV" collected at a different time to "Variables collected at the first day of NIV"? Were separate models fit including data from all NIV patients and only data from patients who had 7 or more days of NIV? It would be more appropriate to fit two separate models, and report the results in two separate tables. e. Care needs to be taken not to overfit models: recall the rule of thumb for logistic regression of 10 events per variable (although note that it appears that this rule can be relaxed somewhat: Answer: S/T means bilevel positive airway pressure in an assist control mode. We have explained this issue in methods section as "S/T, a bilevel positive airway pressure system used in assisted-control mode".
Question 4: 4. The authors state that patients who reached intubation criteria (so basically failed NIV) but had a not-to-intubate order, were continued on NIV. These patients form a significant proportion of patients who received NIV > 14 days in this study (27.5%). Was continuation of NIV in this specific subgroup of patients perhaps part of a palliative care plan? In any instance, this is a complex issue, with significant between countries and between cultures differences. The observed results of this study are therefore difficult to extrapolate outside of the setting where this study was performed. For example, in many settings, when NIV fails and a patient is not for intubation, NIV would be ceased and the goals of care would be changed to comfort care. The association of do-not-intubate order with prolonged NIV as reported by the authors fully depends on the end-of-life decisions made in situations like these. In a health care system where end-of-life and withdrawal of NIV is common practice in patients who fail NIV and are not for intubation, the NIV duration likely would be shorter, not longer. The authors could expand on this issue in the discussion. The process and reasons for do-notintubate orders in the hospital this study was performed would also be of value to readers. What was the role of the patient in the decision-making process? Answer: Different countries and different ICUs have different protocols to deal with do-not-intubate orders. We have searched the literature and found that many ICUs used NIV in patients with a do-notintubate order, and some patients did receive benefits from NIV. Some literature we list as follows: (1 In our study, patients with do-not-intubate orders included some patients with palliative care. In our hospital, patients and their families have the rights to decide to use NIV or not. We fully agreed with that in patients with do-not-intubate orders, the duration of NIV was shorter if the NIV was terminated when the patient required intubation. However, in our hospital, we used NIV in this situation to make the patients comfortable as a palliative care. As many countries and ICUs used NIV as a palliative care, this article is still valuable to them. We also have disused this issue in discussion section "However, cultural norms and ethics differ among different countries. In some countries, NIV may be terminated in palliative care patients with a DNI order when they require intubation; this would lead to a shorter NIV duration. However, in other countries, NIV may be used in palliative care [31] . In the present study, we enrolled patients who received NIV as palliative care with a DNI order. We believe this is valuable to patients and clinical practitioners who use NIV in this situation.".
Question 5: 5. Please provide (as supplemental files) the process and results of the univariate and multiple logistic regression analysis to identify predictors for prolonged NIV. Answer: As other reviewers also point out this problem, we have added the univariate analyses in Table 2 and 3.
Question 6: 6. Please describe the methods (including statistics) used to identify independent risk factors for death in hospital, as reported in Table 4 . Answer: The method used to identify independent risk factors for death in hospital is the same as that used to identify independent risk factors for prolonged NIV. We have clarified this issue in methods section. Answer: We agree with that P/F ratio < 150 is associated with mortality in ARDS. However, as our study enrolled patients who used NIV due to various reasons, we only found P/F ratio < 150 was associated with mortality in univariate but not multivariate analyses.
Question 9: 9. The authors could expand on the study limitations. At a minimum, they should emphasise this is a single centre observational study. Also, the baseline characteristics between the 2 groups were significantly different, with more patients having pneumonia and lung cancer in the long NIV group.
Answer: We have added this issue in limitation section. We revised the limitation as follows. Our study had several limitations. First, we enrolled subjects who used NIV only. As patients who use both NIV and invasive mechanical ventilation may have longer ICU/hospital stays, our study may underestimate the resource use of patients who only received NIV. In addition, our selection method may have led to an artificially high number of DNI orders relative to the general population. Thus, explanation of DNI order is an independent risk factor for prolonged NIV should be cautious. Second, this was a single-center observational study. NIV was managed in the context of the local culture and our hospital protocol. As different centers may have different protocols, extrapolating our results to other centers should be done cautiously. Third, patients who received prolonged NIV had higher rates of pneumonia and pulmonary cancer. When we considered this in multivariate analyses, these patients did not remain in the final model. This indicates that these variables contribute little to the final model.
Response to reviewer #2 We believe that our study is valuable for patients and clinical practitioners in whose country NIV is used if do-not-intubate order is made. We have discussed this issue in discussion section (third paragraph of the discussion section).
Question 2: Table 3 : severe hypoxemia (PaO2/FiO2<150) at the first day is independently associated to prolonged NIV. Specifical analysis of these patients should be performed to understand their prognostic and associated factors. Answer: We agree with your opinion that specifical analysis in severe hypoxemia is valuable. However, our study is aimed to analyze the resource use, characteristics, and outcomes of prolonged NIV.
Here, we omitted to analyze the prognostic and associated factors in patients with severe hypoxemia.
Question 3: Among the results the comparison of the NIV days "used" by patients ventilated 7 days or more should be analyzed with the perspective of mortality, morbidity and costs. Answer: We did not record the costs at the study design. As the study have elapsed 7 years, it is difficult to search the costs in each patient. So, this variable is missed. However, we have record the mortality, and added it in Table 5 .
Question 4: The statistical analysis should be totally revised, DNI order and prolonged NIV shouldn't be analyzed separately because they are confounding factors. Answer: We fully agree with your opinion. When we analyzed the risk factors associated with death in hospital, both DNI order and prolonged NIV were entered into multivariate analysis. And these results were reported in table 4. However, it must be separated when we analyzed the risk factors associated with prolonged NIV in multivariate analysis because prolonged NIV is a dependent variable and DNI order is a covariant variable.
Question 5: Finally, Analyze of resource used (NIV days "used" by patients ventilated 7 days or more) is a good idea but it should be analyzed with the perspective of mortality, morbidity and costs. Answer: We did not record the costs at the study design. As the study have elapsed 7 years, it is difficult to search the costs in each patient. So, this variable is missed. However, we have record the mortality, and added it in Table 5 .
Question 6: Conclusion: To my point, the question of this manuscript should be readdressed and the analysis of prolonged VNI should be done on the light of DNI order. The main subject here is the ventilation for DNR patients. Furthermore, the time of DNR decision is crucial for the discussion, was it defined before or at ICU admission or latter after a first line treatment failure ? Answer: We fully agree with your opinion. We have clarified the proportion of DNI in results section "The rate of DNI orders was 9.1% (140/1539)" Furthermore, we also clarified this issue in conclusion "Our data indicate the resource use, characteristics, and outcomes of prolonged NIV in patients with a relatively high proportion of DNI orders.".
According with our hospital protocol, the DNR decision was mad by patients or their families. We have clarified this issue in methods section as "A do-not-intubate (DNI) order can be made at ICU admission or at NIV as a first-line treatment failure. It was decided by patients themselves or their families.".
Question 7: This manuscript needs English editing. Page 8 line 49: change avoid aspiration for "to limit aspiration risk" Page 9 line 10: I don't understand the sentence: "Intubation was referenced the criteria we described previously. Answer: An English speaker has helped us to check the language, and the two points mentioned above have revised.
Response to reviewer #3 Our study is a single-centre observational study. We prospectively collected data from 2011 to 2017. We have clarified this issue in title "Resource use, characteristics, and outcomes of prolonged noninvasive ventilation: A single-center observational study in china" Question 2: 2. The restriction to patients who received only NIV throughout their ICU stay is problematic from both analytic and generalizability standpoints. For example, there is face validity for why DNR status would be associated with prolonged NIV, but restriction to patients who received only NIV would select for/enrich for patients with DNR status. In terms of generalizability, identifying a patient as "similar to the study patients" would seem to require knowing how their clinical course plays out (i.e., whether or not they received MV during their ICU stay) at its onset. There needs to be more discussion for why this restriction was made and how it impacts the results and their interpretation and generalizability. Answer: We fully agree with your opinions that only NIV population may limit the generalizability. However, if we enrolled patients both used invasive and noninvasive ventilation, it would be very complex to analyze. Patients both used invasive and noninvasive ventilation may present several conditions as follows: ⑴first invasive and then noninvasive, ⑵first noninvasive and then invasive, ⑶ first invasive and then noninvasive, if re-intubation occurred, it should be switch to invasive again, ⑷ first noninvasive and then invasive, if prophylactic NIV was used in postextubation, it should be switch to noninvasive again. Of course, there may be other conditions such as noninvasive + invasive (NIV failure and intubation) + noninvasive (prophylactic use after extubation) + invasive (extubation failure and reintubation). So, we only restricted to NIV patients. We have clarified the limitations in limitation section as follows "Our study had several limitations. First, we enrolled subjects who used NIV only.
As patients who use both NIV and invasive mechanical ventilation may have longer ICU/hospital stays, our study may underestimate the resource use of patients who only received NIV. In addition, our selection method may have led to an artificially high number of DNI orders relative to the general population. Thus, explanation of DNI order is an independent risk factor for prolonged NIV should be cautious. Second, this was a single-center observational study. NIV was managed in the context of the local culture and our hospital protocol. As different centers may have different protocols, extrapolating our results to other centers should be done cautiously. Third, patients who received prolonged NIV had higher rates of pneumonia and pulmonary cancer. When we considered this in multivariate analyses, these patients did not remain in the final model. This indicates that these variables contribute little to the final model" Question 3: 3. What is the justification for defining prolonged NIV as 14 days? What is the justification for deriving additional predictors at day 7 for an additional 7+ days of NIV? Answer: The cut-off value of prolonged mechanical ventilation in invasive mechanical ventilation or prolonged ICU stay is 14 days. Some references we listed as follows: (1) In addition, many studies used ordinal variable to report the association between outcomes because it is easy to explain the association between outcomes. If the pH and P/F keep continuous variable, it may be difficult to explain the outcomes. For example, it is difficult to explain the outcomes is different in patients with pH = 7.36 and 7.45. However, it is easy to explain the outcomes between patients with pH ≥7.35 and ＜7.35. In term of heart rate, we didn't know what the cut-off value was. So, we keep it as continuous variable.
Question 6: 6. For the result that prolonged NIV was associated with increased mortality, was it adjusted for or stratified on DNR status? Or other measures of acuity? Patients with a DNR status will certainly have increased mortality and DNR status will be strongly associated with prolonged NIV. Trying to assess the association of prolonged NIV and mortality would require robust risk adjustment. The authors need to justify that this has been done adequately. Answer: Prolonged NIV was associated with increased mortality. It was adjusted for DNR status. We have added the univariate and multivariate analysis in table 4. Before adjustment, the OR in prolonged NIV for death was 6.2, and after adjustment, the OR was 5.77.
Question 7: 7. Does the term "independent" risk factors imply models adjusting for all other listed covariates? Please confirm/clarify. Please also state clearly what covariates were included in the final models after univariate testing and stepwise regression. Answer: The independent risk factors imply the significant variables in multivariate analysis. Variables with a p value less than 0.2 were entered into the multivariate analysis. We have clarified this issue in statistical section "variables with a p value less than 0.2 in univariate analyses were entered into multivariate analyses (forward stepwise multiple logistic regression analyses) to identify independent risk factors for prolonged NIV"
Response to reviewer #4
Question 1: This is interesting work with a useful dataset. However, the description of the statistical analysis needs some minor (and easy) revisions. First, it is not clear how many models were fit and which variables were used for each one. There are variables that were collected at the beginning of NIV, again on the first day of NIV and again on day 7. I'm not sure what the difference is between the beginning of NIV and the first day of NIV. They sound like the same thing but I'm guessing that the first set of measurements were take prior to NIV while the second set were taken afterwards. How long did you wait for the second ones? I'm also not sure how many models were fit. Was there one model for the beginning, one for the first day, and one for day 7? Did the one for day 1 also use measurements from the beginning or only the measurements for day 1? Was there one model for each of the four outcomes in Table 1 ? Given that less than a quarter of patients received NIV for 7 days, the information at day 7 seems to be aimed at a different question: "who will experience prolonged NIV given that they receive at least 7 days" as opposed to "who will experience NIV?" In summary, the manuscript should clearly state how many models were fit, and which variables were used as candidates to fit each model. Answer: Thanks for your valuable suggestions. There are 3 models used to analyze the variables collected at beginning of NIV, on the first day of NIV and on day 7, respectively. To clarify this issue, we have revised it in table 2 and 3. The variable at the beginning of NIV means it was collected just immediately before NIV use. The first day of NIV means 24 h later. We also have clarified this issue in methods section.
Question 2: A second problem is that if you are proposing that these variables might be useful for predicting prolonged NIV, then it is important to provide some measure of predictive power. The usual way to do that is by reporting a c-statistic or, equivalently, area under the ROC curve, for each model so that readers can get some sense of how well these variables predict the outcomes. Answer: As suggestions, we have added the c-statistic in methods and results section.
Question 3: As a final point, let me also suggest that you may be missing an opportunity by not examining associations between change in the various physiological measures from before to after receiving NIV. For example, the mean heart rate dropped substantially after receiving NIV. It seems likely that some patients experienced larger drops than others and that the magnitude of the drop might well be at least as predictive as the fvalue itself. This is certainly not necessary to rewriting the current manuscript so I leave it up to you as to whether or not you would like to pursue it. Answer: As your suggestion, we have re-analyzed the data and found that there were no significant differences in the drops between beginning and first day of NIV. So we did not add this issue in results section.
Response to reviewer #5 Question 1: 1. Much of the analysis focusses on splitting patients into those with and without prolonged NIV, where the definition of prolonged NIV is NIV lasting for 14 or more days. This dichotomisation appears to be somewhat arbitrary: why not define prolonged NIV as that which lasts for 10 or more days, for example. Although it is useful to categorise NIV duration when comparing resource use, it may be more informative to analyse duration of NIV using Cox proportional hazards models, for example. This would then allow consideration of the impact of characteristics on the hazard of NIV discontinuation. Answer: The cut-off value of prolonged mechanical ventilation in invasive mechanical ventilation or prolonged ICU stay is 14 days. Some references we listed as follows: (1) . So, we believe that the logistic regression analysis is reasonable in our study.
Question 2: 2. How were deaths dealt with in the analysis? It is possible that patients who died after starting NIV, but prior to 14 days on NIV were sicker in measured and unmeasured ways than patients who remained on NIV. Were patients who died prior to 14 days on NIV included in the analysis? What impact might this have on estimated associations? Answer: As suggestions, we have re-analyzed the data and added a table (Table 3) to report the outcomes. This table excluded the patients who died after starting NIV, but prior to 14 days on NIV.
The association was strengthened after revision.
Question 3: 3. It is unclear to me how the results reported in Tables 3 and 4 align with the analysis described on lines 37-52 of page 8 of the manuscript. I have a number of comments about these tables: a. On page 8, it is stated that "…variables with p-value less than 0.2 in univariate analysis were analysed by stepwise multiple logistic regression analysis to find the independent risk factor for prolonged NIV." Was the same method applied to obtain the results in Table 4 ? b. What was the complete set of variables considered for each of these outcomes? The results of fitting the univariable models should also be presented in these tables, as well as the results of the multivariable models.
c. Was forward or backward stepwise regression used? Stepwise approaches to building regression models are generally not recommended, due to p-values not accurately reflecting the entire modelbuilding process. P-values from models built in this way should be interpreted very cautiously. d. Answer: Figure 2 is aimed to report how many resources were used in NIV patients. But it is difficult to understand. So, we delete this figure, and report the outcomes included duration of NIV, ICU stay, hospital stay, and hospital mortality in table 5.
Question 5: 5. Strengths and limitations: "Exclusion of patients who received invasive and noninvasive ventilation may skew the results". It is unclear how this exclusion may bias the results: please provide further details. Answer: We have revised this issue as "Our study had several limitations. First, we enrolled subjects who used NIV only. As patients who use both NIV and invasive mechanical ventilation may have longer ICU/hospital stays, our study may underestimate the resource use of patients who only received NIV. In addition, our selection method may have led to an artificially high number of DNI orders relative to the general population. Thus, explanation of DNI order is an independent risk factor for prolonged NIV should be cautious. Second, this was a single-center observational study. NIV was managed in the context of the local culture and our hospital protocol. As different centers may have different protocols, extrapolating our results to other centers should be done cautiously. Third, patients who received prolonged NIV had higher rates of pneumonia and pulmonary cancer. When we considered this in multivariate analyses, these patients did not remain in the final model. This indicates that these variables contribute little to the final model.". see that in the caption of Table 4 to help assess whether the model has been subject to overfitting (i.e. fewer than 10 events per variable).
VERSION 2 -AUTHOR RESPONSE
Response to reviewers' comments
Response to reviewer #1 Question 1: Introduction. Please remove the words "even worse" and rephrase this statement.
Answer: We have revised this issue.
Question 2: Results. Heart rate and pH on day 1 and 7: please add 95% confidence intervals to the odds ratio.
Response to reviewer #4 Question 1: The authors have addressed my concerns and I am happy with the current manuscript.
Answer: Thanks for your value suggestions.
Response to reviewer #5 Question 1: I remain concerned about how patients who dies prior to 14 days were dealt with in the analysis. In my second comment regarding the originally submitted paper, I had asked how patients who died prior to 14 days, and thus would not have prolonged NIV, were dealt with in the analysis. My intention was not to recommend a re-analysis where these patients were excluded, but rather to urge the authors to clarify how these patients were dealt with in their analysis. Excluding those patients who did die within 14 days does not seem to be a good idea, and may induce selection bias. I recommend that the authors consider approaches to the analysis as described in Hernan "How to estimate the effect of treatment duration on survival outcomes using observational data", BMJ (2018) to ensure that the estimates reported are meaningful and useful.
Answer: Thanks for your value suggestions. We have read the recommended methods to estimate the effect of treatment duration on survival outcomes. The aim of this method is to access the effect of one treatment. However, our study is aimed to access the resource use in patients with prolonged NIV. The sicker patients are more likely to die prior to 14 days. If they survived, they would be required longer NIV. However, in real life, the patients who died prior to 14 days accounted less ICU resources. Our study reflects the real condition. It provides some references for NIV management and decision makers.
In addition, we have searched the articles about the similar topic such as prolonged mechanical ventilation and long-term stay in ICUs. No studies deal with the death as the methods you mentioned. In these studies, the dead patients were left in the analysis. Some studies make a subgroup analysis excluded the dead patients. So we believe the analysis is reasonable left the dead patients in the model. We listed some articles as follows.
